ARVC

Clinical trials for ARVC explained in plain language.

Never miss a new study

Get alerted when new ARVC trials appear

Sign up with your email to follow new studies for ARVC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Experimental antibody IC14 tested in rare heart condition

Disease control Completed

This early-phase trial tested IC14 (atibuclimab), an antibody that targets inflammation, in one person with arrhythmogenic cardiomyopathy (ACM), a rare heart muscle disease that can cause dangerous heart rhythms. The study measured safety, blood markers of inflammation, and heart…

Matched conditions: ARVC

Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC

ARVC

Get alerted when new ARVC trials appear

Experimental antibody IC14 tested in rare heart condition